According to BioMarin Pharmaceutical's latest financial reports the company's total debt is $0.60 Billion USD. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | $0.60 B | -45% |
2023-12-31 | $1.09 B | 0.22% |
2022-12-31 | $1.09 B | 0.35% |
2021-12-31 | $1.08 B | 0.24% |
2020-12-31 | $1.08 B | 26.56% |
2019-12-31 | $0.85 B | 3.42% |
2018-12-31 | $0.83 B | -29.29% |
2017-12-31 | $1.17 B | 71.9% |
2016-12-31 | $0.68 B | 3.16% |
2015-12-31 | $0.66 B | 3.02% |
2014-12-31 | $0.64 B | -1.93% |
2013-12-31 | $0.65 B | 88.26% |
2012-12-31 | $0.34 B | -0.03% |
2011-12-31 | $0.34 B | -7.73% |
2010-12-31 | $0.37 B | -24.05% |
2009-12-31 | $0.49 B | -12.46% |
2008-12-31 | $0.56 B | 14.16% |
2007-12-31 | $0.49 B | 115.57% |
2006-12-31 | $0.23 B | 2.88% |
2005-12-31 | $0.22 B | -17.2% |
2004-12-31 | $0.27 B | 116.67% |
2003-12-31 | $0.12 B | |
2001-12-31 | $5.55 M | 6589.16% |
2000-12-31 | $0.08 M | -25.23% |
1999-12-31 | $0.11 M | 11% |
1998-12-31 | $0.1 M |